Medical Xpress

APRIL 20, 2023

A new study from a team led by researchers at the Johns Hopkins Bloomberg School of Public Health found that signs of common infections in a sample of middle-aged and older adults were associated with poorer performance on a test of global cognitive function.

Research 75

Research 75

Scienmag

NOVEMBER 19, 2020

Patients who received the combination therapy had increased cognition and functioning Credit: UCLA Health FINDINGS UCLA scientists and colleagues found the use of long-acting antipsychotic medication combined with the use of cognitive training in group settings led to improved cognition and increased productivity.

Scientist 97

Scientist Production Research Medicine 97

pharmaphorum

JANUARY 17, 2023

UK digital brain health company Cambridge Cognition has bolstered its speech analysis capabilities with the acquisition of Winterlight Labs of Toronto, Canada, in a cash and stock deal worth £7 million ($8.6 The post Cambridge Cognition buys vocal biomarker firm Winterlight appeared first on.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Marketing 104

XTalks

JANUARY 13, 2022

As a result, elderly people who remain active can maintain brain health and prevent cognitive decline. While the positive effects of exercise on cognitive health have been shown in animal models, it has been more difficult to demonstrate in humans. Key Brain Proteins Maintain Cognitive Health.

Protein 98

Protein Research Regulation Life Science 98

Medical Xpress

MARCH 28, 2023

As the changes in the brain function starts 10–20 years before the clinical onset of Alzheimer's disease, there is a strong interest in the identification of early markers that can be predictive of future mental health/cognitive decline. This is something that we researchers at the Karolinska Institute are on the lookout for.

Research 75

Research 75

pharmaphorum

SEPTEMBER 10, 2021

A digital health company focusing on neurodegenerative disorders – Neuroglee Therapeutics – has raised $10 million in first-round funding to roll out a virtual neurology clinics for people with cognitive problems caused by dementia. Neuroglee raised $2.3 million in early funding last December.

Development 104

Development 104

pharmaphorum

MAY 4, 2022

Cognitive problems affecting memory and attention can be substantial and long-lasting in patients who suffer severe COVID-19 infections, according to a study by researchers in the UK. ” Notably, the pattern of cognitive deficits was different than might be seen in people with dementia or normal age-related decline. .”

Scientist 104

Scientist Clinical Trials Clinical Trials Development 104

pharmaphorum

APRIL 8, 2021

There are currently no approved treatments for cognitive impairments in COVID-19 survivors. There’s still little data on the proportion of COVID019 survivors who go on to develop lingering cognitive problems. The organisations say they aim to begin clinical recruitment for the studies within the next month.

Clinical Trials 127

Clinical Trials Clinical Trials Development Medicine 127

pharmaphorum

JANUARY 27, 2022

The digital health company, which developed the first prescription gaming app to be approved by the FDA, will swell its coffers by more than $410 million gross once the deal go through. “They have also laid the groundwork to treat a wide range of other cognitive issues affecting tens of millions of people around the world.”

Licensing 98

Licensing Licensing Development Medicine 98

pharmaphorum

JUNE 23, 2022

Eisai’s digital tool to allow self-assessment of cognitive performance – NouKNOW – will be used in a Japanese project aimed at improving the management of dementia. It provides a brain performance index (BPI) score to allow users to track their progress, and gives advice on lifestyle changes intended to maintain brain health.

Trials 137

Trials Development Drugs 137

Drug Discovery World

APRIL 20, 2023

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. Given the numbers involved, these persistent symptoms likely represent great future challenges for healthcare systems.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

The Pharma Data

DECEMBER 28, 2020

Middle-Age Sleep Patterns Tied to Subsequent Cognitive Decline. 28, 2020 — Longer time to fall asleep is associated with greater subsequent cognitive decline among middle-aged Hispanic adults, according to a study published online Dec. Cognitive function was evaluated at a seven-year interval. Professional.

Medicine 52

Medicine Research 52

Scienmag

MAY 6, 2021

Younger ‘subjective age’ can have functional health benefits, study finds WASHINGTON — People who feel younger have a greater sense of well-being, better cognitive functioning, less inflammation, lower risk of hospitalization and even live longer than their older-feeling peers.

Gerontology 41

Gerontology Medicine 41

The Pharma Data

MAY 26, 2023

“Cognitive aging is a top health concern for older adults, and this study suggests that there may be a simple, inexpensive way to help older adults slow down memory decline,” says study leader Adam M. Many older people take vitamins or dietary supplements under the assumption that they will help maintain general health.

Research 40

Research Trials Clinical Trials Clinical Trials 40

pharmaphorum

MARCH 31, 2022

University College Dublin spinout Kinesis Health Technologies, which has developed a range of wearable sensors to assess the physical capabilities of patients, has been bought by US company Linus Health for an undisclosed sum. The post Irish wearables firm Kinesis bought by Linus Health appeared first on.

Development 104

Development Research 104

XTalks

MARCH 6, 2024

It also emphasizes the importance of brain health across the lifespan, advocating for strategies to maintain brain function, improve mental health and enhance quality of life. Cognitive decline in dementia frequently leads to a loss of independence and the need for continuous care.

FDA Approval 69

FDA Approval In-Vitro Research Marketing 69

Trialfacts

JULY 31, 2023

Researchers at the University of Kansas Medical Center are studying whether people with Alzheimer’s or mild cognitive impairment can improve their memory and thinking abilities by changing the mix of the foods they eat over a 12-week period. Qualified health professionals will monitor your health as it relates to the study.

Research 52

Research Nurses Insulin Medicine 52

The Pharma Data

AUGUST 15, 2021

Further analysis of the data indicated that those who received mechanical ventilation to help them breathe whilst in hospital had the greatest impairment on cognitive tasks. Online cognition tests. The study found a relationship between deficits in overall cognitive performance and severity of respiratory symptoms experienced.

Research 52

Research Vaccination Vaccine Development 52

pharmaphorum

DECEMBER 2, 2022

protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD (collectively known as early AD), with confirmed presence of amyloid pathology in the brain – were presented at CTAD in San Francisco, California and simultaneously published in the prestigious NEJM.

Trials 57

Trials Clinical Trials Clinical Trials Medicine 57

XTalks

APRIL 22, 2021

Children are the greatest consumers of added sugar and while high sugar intake has long been associated with negative health effects such as obesity and heart disease, little has been known about the link between sugar and brain development. Sugar and Brain Development. Sugar-Induced Changes in the Gut Microbiome.

Development 76

Development Bacteria Research Regulation 76

pharmaphorum

JANUARY 27, 2022

“There’s a clear momentum from some of the larger companies to jump into this, but I think the main way VR will show up as being an important contributor to the pharma and digital health industries is by being a bridge – as being an adjunct to combination therapy,” Greenleaf said. Neurotoxicity needs to be monitored.

Production 142

Production Behavioural Health Development Clinical Trials 142

The Pharma Data

MARCH 1, 2022

The mechanism is currently being evaluated for the potential treatment of cognitive impairment and other symptoms associated with a range of neuropsychiatric and neurodegenerative disorders, such as Alzheimer’s disease and major depressive disorder. senior vice president, R&D, chief scientific officer, AbbVie.

Protein 52

Protein Licensing Licensing Development 52

Drug Discovery World

APRIL 23, 2024

Whereas once it was thought that mild traumatic brain injuries were harmless and symptoms would disappear after a few days of rest, we now know that rest is not enough – these are a major and ongoing public health issue. The World Health Organization estimates that there are 69 million traumatic brain injuries annually worldwide.

Drugs 59

Drugs Development Life Science Hormones 59

XTalks

JANUARY 17, 2024

BrainSee is a software as a service (SaaS) platform powered by AI that can assist physicians in determining the prognosis of patients who have amnestic mild cognitive impairment (aMCI). Not everyone with aMCI will progress to Alzheimer’s, but they are at a higher risk compared to those without any cognitive impairment.

FDA Approval 59

FDA Approval Drugs Production Marketing 59

pharmaphorum

NOVEMBER 30, 2021

Eisai has licensed rights to a cognition-checking algorithm developed by Australian digital health company Cogstate, which it uses in an app – called NouKNOW – that allows people to check their brain health. The network already has 2.4

Development 57

Development Licensing Licensing Trials 57

Drug Discovery World

AUGUST 23, 2022

The National Agency for Safety of Medicines and Health Products (ANSM) gave the go-ahead to Bayer AG to conduct the clinical trial through its subsidiary BrainVectis to investigate its gene therapy, BV-101 in the treatment for Huntington’s Disease (HD). .

Gene Therapy 98

Gene Therapy Gene Trials Clinical Trials 98

XTalks

AUGUST 20, 2021

The COVID-19 pandemic has had wide-ranging health impacts outside of infection with the coronavirus itself. Remote Cognitive Assessments. A large part of dementia and Alzheimer’s research and clinical care involves routine cognitive assessments. These are typically conducted in person in clinical labs at research institutes.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Research 98

XTalks

SEPTEMBER 2, 2021

Non-invasive plasma tests are an ideal way to monitor AD onset and progression before the occurrence of cognitive decline and pathogenic accumulation of amyloid beta plaques in the brain. Related: AAIC 2021: Insights into COVID-19 Impacts on Cognitive Health.

Protein 105

Protein DNA Antibody Genome 105

Drug Discovery World

AUGUST 24, 2022

The company is focused on developing novel mechanisms that address synaptic dysfunction underlying neuropsychiatric and cognitive disorders, including major depressive disorder (MDD). Current therapies for mental health disorders are extremely inadequate and patients need better options.

Packaging 52

Packaging Packaging Medicine Development 52

XTalks

MARCH 26, 2024

World Bipolar Day, observed on March 30th each year, is an important global awareness day focusing on bipolar disorder and eliminating the social stigma often associated with mental health issues. The psychotherapy options include cognitive–behavioral therapy, psychoeducation and family therapy.

Life Science 116

Life Science Development Drugs Research 116

pharmaphorum

MAY 27, 2022

Digital health company Akili Interactive has agreed a deal that could see its gamified therapy for attention-deficit hyperactivity disorder (ADHD) hosted on the creative gaming platform Roblox, used by around 55 million users worldwide.

Cosmetics 93

Cosmetics Marketing Medicine Development 93

pharmaphorum

AUGUST 22, 2022

In a statement , Akili – part of the Puretech group – said that the proceeds will fund the launch of EndeavorRx, its FDA-cleared and CE Mark-certified DTx for attention-deficit hyperactivity disorder (ADHD), which is used to improve attention function in children aged eight to 12. — Chamath Palihapitiya (@chamath) August 19, 2022.

Marketing 57

Marketing Development Medicine 57

Trialfacts

AUGUST 18, 2023

Researchers at the University of Texas at Austin are trying to validate a tool that could potentially be used to identify which patients are at higher risk of brain and cognitive problems that can occur following the diagnosis and treatment of breast cancer. Qualified health professionals will monitor your health as it relates to the study.

Research 52

Research Engineer Doctors Doctor 52

The Pharma Data

AUGUST 1, 2021

In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San Antonio reported July 29 at the Alzheimer’s Association International Conference. Snyder, PhD, Gabriel A.

Containment 52

Containment Research Development 52

pharmaphorum

DECEMBER 20, 2022

Roughly half of all patients exhibit co-occurring mental and/or behavioural health disorders. The serious mental health condition alters a person’s perception of reality and impacts how they think, feel, and behave. Seeing the pipeline of PDTs growing reflects our commitment to mental health.”.

Behavioural Health 52

Behavioural Health Development Research 52

The Pharma Data

MAY 5, 2022

Cognitive impairment as a result of severe COVID-19 is similar to that sustained between 50 and 70 years of age and is the equivalent to losing 10 IQ points, say a team of scientists from the University of Cambridge and Imperial College London. 16 patients were put on mechanical ventilation during their stay in hospital.

Research 52

Research Scientist 52

VirTrial

OCTOBER 6, 2023

Digital health technology (DHT) solutions are now widely adopted and applied in today’s clinical trials.   Primary research with participant groups and clinical trial site staff, including focus groups, surveys, qualitative research interviews, usability testing, and cognitive testing. Evidence assessment. 

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research 52